Trending Topics

Bakery China 2026 Concludes Successfully, Advancing Global Integration and Innovation in the Bakery Industry

2026-06-01 12:37 7686

SHANGHAI, June 1, 2026 /PRNewswire/ -- Bakery China 2026, the 28th edition of the exhibition, concluded successfully on May 23 at the National Exhibition and Convention Center (NECC) in Shanghai, reinforcing its role as a major global platform for the bakery and confectionery industry.

KLN Receives High Recognition in ESG Performance, Achieves Highest AAA Rating in MSCI ESG and Wins HKQAA Hong Kong Green and Sustainability Contribution Awards 2026

2026-06-01 12:19 5881

HONG KONG, June 1, 2026 /PRNewswire/ -- KLN Logistics Group Limited ('KLN'; Stock Code 0636.HK) is pleased to announce that its exceptional environmental, social and governance (ESG) performance has earned it an upgrade in MSCI ESG Rating to the highest tier of AAA rating. KLN is also the proud r...

Minghui Pharmaceutical and Qilu Pharmaceutical Co-Announces Updated Clinical Data of MHB088C (QLC5508) from Phase I/II study in Heavily Pretreated mCRPC Patients at 2026 ASCO Annual Meeting

2026-06-01 12:00 8441

HANGZHOU and SHANGHAI, China, June 1, 2026 /PRNewswire/ -- Minghui Pharmaceutical ("Minghui"), a late-stage clinical biopharmaceutical company focused on developing innovative therapies for oncology and autoimmune diseases, todayannounced updated clinical data from its Phase I/II study evaluating ...

MMA INNOVATE Vietnam 2026 to Gather Leading Voices in Marketing and Technology

2026-06-01 11:51 5000

HO CHI MINH CITY, Vietnam, June 1, 2026 /PRNewswire/ -- With just over 10 days to go, MMA INNOVATE Vietnam 2026 is set to take place on June 10–11, bringing together one of the most anticipated gatherings for Vietnam's marketing, technology, and innovation communities. Under the theme "Accelerat...

Supermicro Launches New Server Solutions with Intel Xeon 6+ Processors to Reduce TCO and Accelerate Time-to-Online for Large-Scale Cloud and Data Centers

2026-06-01 11:00 7779

* 12 new systems across Hyper, SuperBlade®, FlexTwin™, and GrandTwin® families offer industry-leading core density with up to 576 efficiency cores per server * Breakthrough performance-per-watt and energy efficiency designed to lower TCO and reduce power consumption in high-density cloud and ...

ASCO 2026 | Oricell's GPC3 CAR-T Ori-C101 Hits 66.7% ORR in Late-Line HCC, Signaling Best-in-Class Potential

2026-06-01 10:37 7529

CHICAGO, May 31, 2026 /PRNewswire/ -- Oricell Therapeutics, a clinical-stage biotech company pioneering cancer immunotherapy, today announced that its lead asset, Ori-C101, a GPC3-targeted CAR-T therapy, achieved a 66.7% objective response rate (ORR) in patients with Late-line refractory hepatoce...

Changingtek Robotics Launches High-Precision Tactile Sensing Data Collection Hand, Uhand

2026-06-01 10:09 4680

SUZHOU, China, June 1, 2026 /PRNewswire/ -- Changingtek Robotics has launched globally its in-house developed high-precision tactile data collection hand. The device delivers synchronized multi-dimensional and multimodal data capture to support embodied intelligent robot research, precision manip...

IEI Showcases Resilient Edge AI Platforms at COMPUTEX 2026: Advancing AI Deployment Across Industrial Applications

2026-06-01 10:12 4560

NEW TAIPEI CITY, June 1, 2026 /PRNewswire/ -- IEI Integration Corp. (IEI) announced its COMPUTEX 2026 lineup (TaiNEX 2, Booth #P0114). Under the theme "Resilient Edge AI Platforms: T...

Tencent Cloud Recognized as a "Challenger" in Gartner® Magic Quadrant™ for CPaaS for the Fourth Consecutive Year

2026-06-01 10:00 7315

Positioned Highest in Asia Pacific for Ability to Execute. Driving Breakthroughs in AI‑Powered CPaaS and Global Expansion HONG KONG, June 1, 2026 /PRNewswire/ -- Tencent Cloud, the cloud business of global technology company Tencent, today announced that it has once again been recognized as a Ch...

Mahindra and Manulife Insurance JV Moves Ahead; Gets Approval from Ministry of Corporate Affairs

2026-06-01 09:16 8359

Entity to be called "Mahindra Manulife Insurance Limited"; a 50:50 partnership MUMBAI and HONG KONG, June 2, 2026 /PRNewswire/ -- Mahindra and Manulife announced their partnership to create a life insurance business on November 12, 2025. Both companies have confirmed the incorporation of the JV c...

Deloitte appoints Robert Hillard as Asia Pacific Chief Executive Officer

2026-06-01 09:00 4466

HONG KONG, June 1, 2026 /PRNewswire/ -- Deloitte Asia Pacific today announced the appointment of Robert Hillard as Asia Pacific Chief Executive Officer, commencing a four-year term. Mr Hillard's appointment was endorsed by partners across Asia Pacific, and he succeeds David Hill following the com...

UOB and FPT sign MoU to advance AI, technology transformation and financial innovation opportunities

2026-06-01 09:00 7267

SINGAPORE, June 1, 2026 /PRNewswire/ -- UOB and global technology corporation FPT have signed a Memorandum of Understanding (MoU) to explore strategic collaboration opportunities in artificial intelligence (AI), digital and technology transformation, and financial services innovation.

Long-term Follow-up Results of CARsgen's Satri-cel as Sequential Therapy After First-Line Treatment for Gastric Cancer Presented at the 2026 ASCO Annual Meeting

2026-06-01 08:15 6319

SHANGHAI, May 31, 2026 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announces that the long-term analysis results of satricabtagene autoleucel ("satri-cel", CT041) (an autologous CAR T-cell product ca...

ASCO 2026 | CStone Presents Updated Clinical Data for CS2009 (PD-1/VEGF/CTLA-4 Trispecific Antibody), Reinforcing Triple-Target Synergy and Delivering Strong Proof-of-Concept

2026-06-01 08:15 7369

First-line NSCLC – Compelling Activity Across All PD-L1 Subgroups In first-line non-small cell lung cancer (NSCLC) patients with high PD-L1 expression (TPS ≥50%), CS2009 monotherapy achieved anobjective response rate (ORR) of 81.3% and a disease control rate (DCR) of 100.0%, with consistent benef...

MICROIP to Debut "AI Vehicle System Business Group" and Edge AI Innovations at COMPUTEX 2026

2026-06-01 08:00 6124

TAIPEI, June 1, 2026 /PRNewswire/ -- MICROIP (TPEx: 7796), specializing in AI software and ASIC design services, will unveil its "AI Vehicle System Business Group" at COMPUTEX 2026 (Booth A1215a, TWTC Hall 1, June 2-5). Echoing the "AI Together" theme, the showcase focuses on edge AI, smart mobil...

D3 Bio Presents First-Line Data for Elisrasib (D3S-001) at ASCO 2026; Next-Generation KRAS G12C Inhibitor Shows Landmark Efficacy in Untreated NSCLC

2026-06-01 08:00 4672

Elisrasib monotherapy delivers an ORR of 78.0% and median PFS of 12.4 months in first-line KRAS G12C–mutant NSCLC (n=41) across all PD-L1 expression levels Combination of elisrasib with pembrolizumab achieves an ORR of 81.3% in first-line KRAS G12C–mutant NSCLC (n=48) across all PD-L1 expression ...

ImmVira Reports 100% Complete Response Rate at 9 Months in Bladder Carcinoma in Situ with MVR-T3011 at ASCO

2026-06-01 08:00 5085

SUZHOU, China, May 31, 2026 /PRNewswire/ -- ImmVira Group ("ImmVira") today announced that preliminary Phase IIa clinical data for MVR-T3011, its lead oncolytic immunotherapy candidate, was presented at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting. As of the data cut-off o...

2026 ASCO | Innovent Presents Preliminary PoC Data of IBI363 (TAK-928) PD-1/IL-2α-bias bispecific fusion protein) in First-line Advanced NSCLC

2026-06-01 08:00 6036

* IBI363 in combination with chemotherapy demonstrated encouraging efficacy signals and manageable safety in the first-line treatment of NSCLC with PD-L1 negative or low expression. The 3→1.5 mg/kg dose group (n=22) showed ORR of 86.4%, confirmed ORR (cORR) of 81.8% (95% CI: 59.7-94.8) and DCR ...

2026 ASCO | Innovent Presents Long-Term Follow-up Results from the PoC Study of IBI363 (TAK-928) (PD-1/IL-2α-bias bispecific fusion protein), Showing Robust Survival Benefits in Advanced Immunotherapy-Resistant Non-Small Cell Lung Cancer

2026-06-01 08:00 5560

* After long-term follow-up, IBI363 monotherapy demonstrated strong overall survival (OS) with a long tail effect in IO-resistant squamous NSCLC and adenoNSCLC * IBI363 has entered a global Phase 3 clinical study (MarsLight-11) for IO-resistant squamous NSCLC; pending regulatory communication...

New Taipei City Showcases Smart Manufacturing Strength at AUTOMATE 2026

2026-06-01 08:00 4822

Exploring New Business Opportunities with Global Buyers TAIPEI, May 31, 2026 /PRNewswire/ -- The New Taipei City Government is leading a delegation of 20 companies specializing in smart manufacturing, automation, industrial AI, and key components to participate in AUTOMATE 2026, one of North Ame...